Heat‐Based Therapies in Hypertension Management: A Systematic Review of Physiological Mechanisms
International Journal of Hypertension · 2026-01 · 2026 (1)
DOI: 10.1155/ijhy/6175586 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Hypertension, online erschienen am 16.11.2026. Verfasst von Isingizwe Stella Matutina und 16 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertension is a major modifiable risk factor for several cardiovascular diseases, leading to the need for investigations of user‐friendly and less costly nonpharmacological interventions, including passive heat therapies. This study synthesized information on heat‐based therapies used in prehypertension and hypertension management, as well as their clinical efficacy, physiological mechanisms, and translational potential.
Methods
We systematically reviewed 13 eligible human studies published between 2000 and 2025 per the PRISMA 2020 checklist, assessed randomized studies with RoB 2 and nonrandomized studies with ROBINS‐I, and used SWiM‐guided narrative synthesis because interventions, populations, comparators, and outcomes were heterogeneous. Certainty was assessed using GRADE. The review protocol was not preregistered.
Results
Acute blood‐pressure reductions and changes in vascular or autonomic markers were reported in some populations, but sustained comparative effects in hypertension remain uncertain. In hypertensive participants, both hot and thermoneutral immersion were associated with reductions in 24‐h blood pressure (BP), limiting heat‐specific attribution. A single pooled effect estimate and corresponding 95% confidence interval were not calculated. The benefits were linked to lower sympathetic activity, more nitric oxide availability, lower endothelin‐1 levels, and less oxidative stress. Outcome‐specific GRADE certainty was very low for SBP and DBP and the assessed mechanistic domains.
Conclusion
Passive heat exposure can produce short‐term reductions in BP and changes in vascular function, but sustained antihypertensive efficacy, particularly when evaluated with 24‐h ambulatory BP in patients with established hypertension, remains uncertain. Mechanistic findings from heart‐failure and peripheral artery disease (PAD) cohorts are indirect evidence for uncomplicated hypertension. Passive heat should not replace established antihypertensive treatment. Safety evidence is limited to selected, often supervised populations, and larger trials with ambulatory BP and systematic adverse‐event assessment are needed.
Zitieren
APA
Matutina, I. S., Ikwuka, D. C., Olubiyi, M. V., Niyodusenga, A., Adeniyi, M. J., Walle, M., Owu, D. U., Okeke, O. C., Onaadepo, O., Feyitimi, A. A., Eze, E. D., Ime, A. U., Jimoh, A., Umar, A. H., Ani, E. J., Alagbonsi, A. I., & Wondimu, D. H. (2026). Heat‐Based Therapies in Hypertension Management: A Systematic Review of Physiological Mechanisms. International Journal of Hypertension, 2026(1). https://doi.org/10.1155/ijhy/6175586
Vancouver
Matutina IS, Ikwuka DC, Olubiyi MV, Niyodusenga A, Adeniyi MJ, Walle M, et al. Heat‐Based Therapies in Hypertension Management: A Systematic Review of Physiological Mechanisms. International Journal of Hypertension. 2026;2026(1). doi:10.1155/ijhy/6175586
BibTeX
@article{Matutina2026,
author = {Matutina, Isingizwe Stella and Ikwuka, David Chibuike and Olubiyi, Makinde Vincent and Niyodusenga, Alphonse and Adeniyi, Mayowa Jeremiah and Walle, Muluken and Owu, Daniel Udofia and Okeke, Onyinye Cynthia and Onaadepo, Olufunke and Feyitimi, Abdul-Rahuf Aderemi and Eze, Ejike Daniel and Ime, Akaninyene Ubong and Jimoh, Abdulazeez and Umar, Abdullahi Hussein and Ani, Elemi John and Alagbonsi, Abdullateef Isiaka and Wondimu, Diresibachew Haile},
title = {Heat‐Based Therapies in Hypertension Management: A Systematic Review of Physiological Mechanisms},
journal = {International Journal of Hypertension},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijhy/6175586}
}
EUVIMED